Nonobstructive Hypertrophic Cardiomyopathy with preserved EF is a well-known ejection fraction preserved heart failure and oral medical therapy is the major treatment. Interatrial shunt devices have preliminarily been shown to be safe and efficacious for the treatment of HFpEF, their utilization in nonobstructive hypertrophic cardiomyopathy patients has not been describe